medigraphic.com
ISSN 1029-3035 (Electronic)

2013, Number S1

<< Back Next >>

Mediciego 2013; 19 (S1)

Charles Bonnet syndrome. Case report and subject revision

Pérez EFA, Betancourt CPO, Romeu YSE, Pérez RE, Román GH

Language: Spanish
References: 25
Page:
PDF size: 104.86 Kb.


ABSTRACT

The case of 77 years feminine patient appears, widow, coming from urban area, with hypertension antecedents, having regular treatment with enalapril 20 mg. everyday, with secondary visual deficit to age-related macular degeneration (ARMD), with progressive loss of visual acuity, she presented complex visual hallucinations in three years of evolution and after being studied by Psychiatry, Ophtalmology and Internal Medicine it was established the diagnosis of Charles Bonnet syndrome. This entity tends to be subdiagnosed in the scope of the health, given to its peculiarity and ignorance on the part of the medical personnel. It shows the main clinical characteristics of the syndrome, physiopathology, risk factors, diagnosis and treatment.


REFERENCES

  1. Muñoz Cortés H, Vargas Rueda A. Síndrome de Charles Bonnet. Rev Colomb Psiquiatr [Internet]. 2007 [citado 5 Sep 2012]; 36(2): [aprox. 8 p.]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0034

  2. Fernández A, Lichtshein B. The Charles Bonnet syndrome: a review. J Nerv Ment Dis. 1997; 185:195-199.

  3. Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: Charles Bonnet syndrome. Surv Ophthalmol. 2003; 48:58-72.

  4. Ffyche DH. Visual hallucinatory syndromes: past, present and future. Dialogues Clin Neurosci. 2007; 9(2): 173-89.

  5. Terao T. Hallucinations in Alzheimer’s disease and Charles Bonnet syndrome. Am J Psychiatr. 2000; 157(12):62.

  6. Chen J, Gómez M, Veit S, O’Dowd MA. Visual hallucinations in blind elderly woman: Charles Bonnet syndrome, an under recognized clinical condition. Gen Hosp Psychiatr. 1996;18:453-55.

  7. Teunisse R. The CBS a large prospective study in the Netherlands. Br J Psych. 1995; 166:254-57.

  8. Folstein M, Folstein S, MCHugh PR. Minimental State: a practical method for grading the cognitive state of the patients for the clinician. J Psychiatr Res. 1975; 12:189-98.

  9. Tejedor JH. Alucinaciones visuales en el anciano. Med Clin. 2002; 118(9):353-6

  10. Mewasingh LD, Kornreich C, Christiaens F, Christophe C, Dan B. Pediatric phantom vision (Charles Bonnet) syndrome. Pediatr Neurol. 2002; 26(2): 143-5

  11. Tan CS, Sabel BA, Goh K-Y. Visual hallucinations during visual recovery after central retinal artery occlusion. Arch Neurol. 2006; 63: 598-600.

  12. Pliskin NH, Kiolbasa TA, Towle VL, Pankow L, Ernest JT, Noronha A, et al. Charles Bonnet syndrome: an early marker for dementia? J Am Geriatr Soc. 1996; 44(9):1055-61.

  13. Evers S, Eliger T. The clinical spectrum of musical hallucinations. J Neurol Sci. 2004; 227(1): 55-6.

  14. González M, De Pablo J, Valdés M. Delirium, la confusión de los clínicos. Rev Méd Chil. 2003; 131: 1051-60

  15. Santhouse AM, Howard RJ, ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain. 2000; 123: 2055-64

  16. Ffytche D, Howard RJ. The perceptual consequences of visual loss: “positive” pathologics of vision. Brain. 1999; 122(7):1247-60.

  17. Howard RJ. Visual hallucinatory syndromes and the anatomy of the visual. Brain. 2000; 123:2055-64.

  18. Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatr. 2002; 73(5): 535-41.

  19. Shiraishi Y, Terao T, Ibi K, Nakamura J, Tawara A. Charles Bonnet syndrome and visual acuity the involvement of dynamic or acute sensory deprivation. Eur Arch Psychiatry Clin Neurosc. 2004; 254(6): 362-64.

  20. Adachi N, Watanabe T, Matsuda H, Onuma T. Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome. Psychiatry Clin Neurosci. 2000; 54(2): 157-62.

  21. Teunisse RJ, Cruysberg JR, Hoefnagels WH, van't Hof MA, Verbeek AL, Zitman FG. Risk indicators for the Charles Bonnet syndrome. J Nerv Ment Dis. 1998; 186(3): 190-2.

  22. Coletti MM, Milano E, Gasverde S, Gianelli M, Giordana MT. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci. 2005; 26: 168-70.

  23. Siddiqui Z, Ramaswmay S, Petty R. Mirtazapine for Charles Bonnet syndrome. Can J Psychiatr. 2004; 49(11): 787-788

  24. Eperjesi F, Akbarali N. Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom. 2004; 87: 149-52

  25. Rovner BW. The Charles Bonnet Syndrome: a review of recent research. Curr Opin Ophthaimol. 2006; 17: 275-277.




2020     |     www.medigraphic.com